Huons Co (243070.KQ) Stock Price

Huons Co Price

KOSDAQ·CLOSED
18,970.00
​
Market closed

Revenue has compounded at 15.6% per year over the past 9 years to 620.77 B KRW. Earnings per share have grown at 12.4% per year over the last 9 years. Huons Co's net margin stands at 6.9%, broadly stable from 7.0% several years earlier. Huons Co currently offers a dividend yield of about 5.54%. The payout ratio is around 29% of earnings. The dividend has grown at 15.1% per year over the past 8 years. Analysts set a median price target of 56,610.00 KRW, implying 198.4% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Huons Co stock price

Access this data via the Eulerpool API

Huons Co business model & stock analysis

Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.

Frequently asked questions about Huons Co

Analysts currently set an average price target of 56,610.00 KRW for the Huons Co stock (median: 56,610.00 KRW), implying +198.4 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Huons Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Huons Co to generate revenue of 651.60 B KRW and earnings per share of 3,520.50 KRW.

Converted at the current exchange rate, the Huons Co share trades at 12.61 EUR (18,970.00 KRW).

The Huons Co share (243070.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (243070.KQ).

The expected revenue of Huons Co is 651.60 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Huons Co is 41.02 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Huons Co is currently 5.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Huons Co stock.

The price-to-sales ratio (P/S) of Huons Co is currently 0.34. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Huons Co stock.

The Eulerpool Quality Score for Huons Co is 5/10.

The ISIN of Huons Co is KR7243070000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Huons Co is 243070.KQ. The ticker symbol is used to trade Huons Co shares on the stock exchange.

Fair ValueTerminal
18,211.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website huons.com
Country
South Korea
Currency
KRW
Initial public offering
Jun 3, 2016
ISIN
KR7243070000
Cusip
Y3772Y132
Market capitalization
229.34 B KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
5.59
P/Ee 2027
4.96
P/S
P/Se
0.34
EV/EBIT
4.80
P/B Ratio
0.61
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.35 %
Dividend
Dividend yield
5.54 %
Est. Dividend Yield
3.16 %
Payout Ratio
28.68 %
Dividend growth Ø5Y
—
Dividend payments per year
3
Dividend paid since
9 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
22.00 %
Last updated Oct 10, 2026, 12:31 PM

Huons Co Peer Group

Huons Co Ticker

KOSDAQ · 243070.KQ

Huons Co FIGI

243070:KS · BBG00BJW1V40243070:KQ · BBG00C1BPC76

All fundamentals and in-depth analysis of Huons Co

Our stock analysis for Huons Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huons Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.